Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease

Area of Science:

• Ophthalmology
• Biomarker Research
• Diagnostic Technology

Background:

• Dry Eye Disease (DED) presents complex symptoms, often overlapping with other conditions, making diagnosis difficult.
• Current diagnostic methods for DED suffer from poor reliability and lack of standardization.
• Identifying specific biomarkers is crucial for understanding DED pathophysiology and categorizing patient subtypes.

Purpose of the Study:

• To review current knowledge of Dry Eye Disease biomarkers.
• To provide an overview of emerging diagnostic technologies for DED.
• To aid healthcare providers in making better-informed DED diagnoses and treatment decisions.

Main Methods:

• Literature review of DED biomarkers, including molecular (MMP-9, cytokines, lactotransferrin, lacritin) and functional (tear osmolarity) markers.
• Review of current point-of-care diagnostic tools (e.g., InflammaDry, I-Pen Tear Osmolarity System).
• Synthesis of biomarker information with emerging diagnostic technologies.

Main Results:

• Key molecular biomarkers like matrix metalloproteinase-9 (MMP-9) and functional biomarkers like tear osmolarity are identified.
• Existing point-of-care tools enable measurement of select biomarkers.
• Despite advancements, a need persists for more reliable and accurate diagnostic devices for DED.

Conclusions:

• Biomarkers are essential for understanding and diagnosing DED.
• Emerging technologies offer improved diagnostic capabilities for DED.
• Further development of reliable diagnostic tools is critical for effective DED management.